Press release
Investigation announced for Long-Term Investors in DexCom, Inc. (NASDAQ: DXCM) shares over possible Wrongdoing by certain directors
An investigation on behalf of current long term investors in DexCom, Inc. (NASDAQ: DXCM) shares.
Investors who are current long term investors in DexCom, Inc. (NASDAQ: DXCM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: DXCM stocks follows a lawsuit filed against DexCom, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: DXCM stocks, concerns whether certain DexCom, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that the defendants failed to disclose the true state of DexCom's salesforce, that DexCom, Inc was not truly equipped to execute on the Company's perceived growth potential, and that as a result of their purchases of DexCom's common stock between January 8, 2024 to July 25, 2024, investors suffered economic loss.
Those who purchased shares of DexCom, Inc. (NASDAQ: DXCM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in DexCom, Inc. (NASDAQ: DXCM) shares over possible Wrongdoing by certain directors here
News-ID: 3903423 • Views: …
More Releases from Shareholders Foundation, Inc.
Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) Long Term should c …
An investigation was announced for current long-term investors in shares of BioAge Labs, Inc. (NASDAQ: BIOA) concerning potential breaches of fiduciary duties by certain directors of BioAge Labs, Inc.
Investors who are current long term investors in BioAge Labs, Inc. (NASDAQ: BIOA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
e.l.f. Beauty, Inc. (NYSE: ELF) Investor Notice: Deadline in Lawsuit on May 5, 2 …
A deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of e.l.f. Beauty, Inc. (NYSE: ELF).
Investors who purchased shares of e.l.f. Beauty, Inc. (NYSE: ELF) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. e.l.f. Beauty, Inc. (NYSE: ELF) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed…
Investigation announced for Long-Term Investors in Revance Therapeutics, Inc. (N …
An investigation was announced for current long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors of Revance Therapeutics, Inc.
Investors who are current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Skyworks Solutions, Inc. (NASDAQ: SWKS) Shareholder Notice: Deadline in Lawsuit …
The Shareholders Foundation announced that a deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of Skyworks Solutions, Inc. (NASDAQ: SWKS) over alleged securities laws violations by Skyworks Solutions, Inc.
Investors who purchased shares of Skyworks Solutions, Inc. (NASDAQ: SWKS) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. Skyworks Solutions, Inc. (NASDAQ: SWKS) stockholders should contact the Shareholders…
More Releases for DexCom
mHealth Market To Witness Superb Growth | Dexcom, WellDoc, Claritas MindSciences
The latest analysis released by HTF MI on "Global mHealth Market Outlook 2020 Survey results" sheds light on how investment and competitive landscape is impacted due to significant changes in the mHealth Industry. The research coverage includes analysis on companies such as Pear Therapeutics, Inc., Ginger.io, Inc., Livongo Health, Withings, Propeller Health, Mango Health, Twine Health, Inc., Digital Therapeutics, Proteus Digital Health, Dexcom, Inc., WellDoc, Inc., Claritas MindSciences, Jawbone, Canary…
Diabetes Monitors Market Is Booming Worldwide | Dexcom, Roche, Medtronic
HTF MI released new intelligence report on "Worldwide Diabetes Monitors Market" aiming to deliver competitive advantage. The study discusses how various medical equipment manufacturers are reinventing their Worldwide Diabetes Monitors business and operating models with future outlook. Some of the Manufacturers considered in the study are Panasonic, Abbott Laboratories, Dexcom, Roche, Medtronic, LifeScan & Sanofi etc.
Get an Inside Scoop of Worldwide Diabetes Monitors Market Studyhttps://www.htfmarketreport.com/sample-report/3587011-worldwide-diabetes-monitors-market
The Worldwide Diabetes Monitors market study…
mHealth Market is Thriving Worldwide | Jawbone, Apple, Dexcom, Omada Health, Wel …
Global mHealth Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global mHealth Market. Some of the key players profiled in the study…
Diabetes Management Software Market- Key Vendors ( Glooko, OneTouch, Dexcom Clar …
The diabetes management software market has been expanding alongside the effort of the healthcare industry to induct the best facilities for treatment and care of diabetic patients. It is expected that the demand for diabetes management software would flow in from private clinics as well as hospitals in the forthcoming years. This is because both of these units witness an influx of patients suffering from diabetes on a daily basis.…
Diabetes Management Software Market by Key Players - Glooko, OneTouch, Dexcom Cl …
The diabetes management software market has been expanding alongside the effort of the healthcare industry to induct the best facilities for treatment and care of diabetic patients. It is expected that the demand for diabetes management software would flow in from private clinics as well as hospitals in the forthcoming years. This is because both of these units witness an influx of patients suffering from diabetes on a daily basis.…
mHealth Market is Booming Worldwide | Jawbone, Apple, Dexcom
HTF MI broadcasted a new title “Global mHealth Market Study 2015-2025, by Segment (Connected Medical Devices (Heart Rate Monitors, Activity Monitors, Electrocardiograph, Fetal Monitoring, and Neuromonitoring), Apps (Weight Loss, Woman Health, Personal Health Record, & Medication), Services (Diagnostic, Remote Monitoring, Consultation)), by Market (B2B (Patients and Caregivers), B2C (Providers, Payers, and Employers)), by Company (Jawbone, Apple, Dexcom)” with 67 pages and in-depth assessment including key market trends, upcoming technologies, industry…
